Excelya is a European contract research organization (CRO) that provides services for the pharmaceutical, biotech, and medical device industries to help with drug development. It offers a wide range of services, from early-phase clinical trials to post-marketing studies, and supports clients through various cooperation models, including consulting and full-service contracts. Founded in 2014, Excelya has grown to become a large, independent company with a global team of experts dedicated to clinical research and development.